For a patient allergic to rifampin, pyrazinamide, and ethambutol but not to isoniazid, is isoniazid monotherapy appropriate for treating active tuberculosis?

No, isoniazid monotherapy is absolutely contraindicated for active tuberculosis

Isoniazid monotherapy must never be used to treat active tuberculosis, regardless of allergies to other first-line drugs, as this will rapidly lead to drug resistance and treatment failure. 1, 2, 3

Why Monotherapy is Dangerous

Single-drug treatment of active tuberculosis is inadequate therapy and explicitly contraindicated by FDA labeling 2. The evidence is unequivocal:

• Resistance develops rapidly: Within large populations of susceptible TB bacteria, resistant cells will quickly become predominant when exposed to only one drug 3
• Treatment failure is inevitable: Multiple case reports document acquired isoniazid resistance developing during monotherapy, even in patients initially thought to have latent infection 4, 5
• Never add a single drug to a failing regimen: This fundamental principle applies universally in TB treatment 6

What You Must Do Instead

Step 1: Verify the Allergies

Before accepting that the patient cannot take rifampin, pyrazinamide, and ethambutol, you need to:

• Obtain detailed allergy history (type of reaction, timing, severity)
• Consider drug desensitization protocols under specialist supervision 7
• Distinguish true allergies from intolerances or side effects that can be managed

The British Thoracic Society guidelines explicitly state that when drug choices are severely limited by resistance or allergies, desensitization may be necessary, performed under cover of two other antituberculosis drugs 7.

Step 2: Build a Multi-Drug Regimen

If allergies are confirmed and desensitization is not feasible, you must construct a regimen using alternative agents:

Recommended approach 8, 9:

• Fluoroquinolones (levofloxacin or moxifloxacin) - strong recommendation for inclusion
• Bedaquiline - strong recommendation for MDR-TB regimens
• Linezolid - strong recommendation for MDR-TB regimens
• Injectable agents (amikacin or streptomycin if susceptibility confirmed) - conditional recommendation
• Cycloserine/terizidone - may be included
• Clofazimine - may be included

Step 3: Ensure Expert Consultation

This patient requires immediate referral to a TB specialist or MDR-TB treatment center 7, 8. The 2019 ATS/CDC/ERS/IDSA guidelines emphasize that treatment of drug-resistant TB or patients with severe drug intolerances must be managed by experts 8.

Critical Pitfalls to Avoid

1. Never start treatment before confirming active disease: If this is actually latent TB infection (positive test, normal chest X-ray, asymptomatic), different rules apply 10

2. Do not confuse this with isoniazid-resistant TB: For confirmed isoniazid-resistant, rifampin-susceptible TB, a 6-month regimen of rifampin, ethambutol, pyrazinamide, and a fluoroquinolone is recommended 8. Your patient's situation is the opposite.

3. Avoid the temptation to "try" monotherapy temporarily: Even short periods of functional monotherapy can select for resistance 4, 5

The Bottom Line

A patient with confirmed active tuberculosis who is allergic to rifampin, pyrazinamide, and ethambutol requires:

• Immediate TB specialist consultation
• A minimum of 4-5 effective drugs from alternative agents
• Likely 18-24 months of treatment duration
• Close monitoring with drug susceptibility testing

Isoniazid alone will fail and create drug resistance. This is not a treatment option.